Publications, Pharmaceutical

A pre-filled syringe platform for vaccines and large volume biologics

Choosing appropriate packaging for a drug is essential since interactions between drug and container can compromise patient safety. This is especially true for biologics and vaccines. This article introduces Aptar Pharma’s PremiumCoat® platform focusing on its application in the manufacture of prefilled syringes. Prefilled syringes are prized for their ability to limit drug waste and for easy administration at the point of use, a factor that makes them useful for seasonal vaccination of the type that may prove necessary for the long-term management of COVID-19. The PremiumCoat® 1 – 3ml plunger format combines a pure bromobutyl formulation with proven ETFE film technology to minimize leachables. It is particularly useful for vaccines and large-volume biologics and facilitates vial-to-prefill projects. Experimental data illustrate key aspects of the system’s performance.

Download Publication
Author(s): Sébastien Cordier Dr. Laure-Hélène Guillemot Audrey Chardonnet
Drug Development & Delivery
5 Oct 2021

This Might Also Be of Interest

20 Jul 2021

Leak Detection for Finished Sterile Containers

Webinars, Pharmaceutical, Innovation & Insights, Market Insights, Product Solutions

Read More
2 Jun 2021

Aptar Pharma discusses how digital solutions improve patient outcomes

Webinars, Pharmaceutical, Innovation & Insights, Device Innovations, Brand Differentiation, Market Insights, Product Solutions

Read More
31 May 2021

Ensuring Functional Performance and Regulatory Compliance of Elastomer Stoppers for M...

Publications, Pharmaceutical, Market Insights, Product Solutions, Innovation & Insights, Device Innovations, Brand Differentiation

Read More
27 Jan 2021

COVID 19: Drug Delivery Options to Succeed Sooner

Webinars, Pharmaceutical, Innovation & Insights, Device Innovations, Market Insights, Product Solutions

Read More
1 9 10 11 12 13 15

Request Access

Close

Requesting access to A pre-filled syringe platform for vaccines and large volume biologics.

  • This field is for validation purposes and should be left unchanged.
Back To Top